Chong Zhao Selected Research

Prostatic Neoplasms (Prostate Cancer)

1/2022	Inhibition of PD-L1-mediated tumor-promoting signaling is involved in the anti-cancer activity of β-tocotrienol.
11/2021	Methylseleninic acid overcomes programmed death-ligand 1-mediated resistance of prostate cancer and lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chong Zhao Research Topics

Disease

128	Nasopharyngeal Carcinoma 03/2024 - 08/2002
87	Neoplasms (Cancer) 04/2024 - 07/2003
33	Neoplasm Metastasis (Metastasis) 03/2024 - 10/2005
13	Liver Cirrhosis (Hepatic Cirrhosis) 12/2023 - 01/2018
7	Inflammation (Inflammations) 04/2024 - 10/2016
7	Mucositis 01/2023 - 10/2003
6	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2014
6	Necrosis 08/2017 - 05/2006
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2023 - 01/2018
4	Ulcerative Colitis 04/2024 - 01/2021
4	Colitis 03/2024 - 01/2021
4	Carcinogenesis 07/2023 - 02/2016
4	Neutropenia 01/2023 - 10/2016
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 07/2014
4	Hypoxia (Hypoxemia) 01/2023 - 03/2006
4	Leukemia 01/2023 - 09/2016
4	Xerostomia 12/2022 - 03/2004
4	Breast Neoplasms (Breast Cancer) 03/2022 - 02/2013
4	Fatigue 01/2022 - 06/2021
4	Fibrosis (Cirrhosis) 05/2021 - 01/2015
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2017 - 01/2014
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2024 - 01/2022
3	Lung Neoplasms (Lung Cancer) 02/2024 - 01/2019
3	Colonic Neoplasms (Colon Cancer) 10/2023 - 02/2020
3	Compression Fractures (Compression Fracture) 09/2023 - 08/2022
3	Stomach Neoplasms (Stomach Cancer) 07/2023 - 02/2011
3	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2023 - 01/2021
3	Infections 01/2023 - 01/2020
3	Leukopenia 01/2023 - 01/2016
3	Nausea 01/2022 - 01/2016
3	Vomiting 01/2022 - 01/2016
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2020
3	Multiple Myeloma 01/2018 - 06/2014
3	Squamous Cell Carcinoma of Head and Neck 04/2017 - 04/2009
2	Glioma (Gliomas) 04/2024 - 11/2004
2	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 11/2004
2	Dysbiosis 04/2024 - 11/2020

Drug/Important Bio-Agent (IBA)

27	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 08/2002
19	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 07/2003
13	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2023 - 01/2013
10	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2008
9	MicroRNAs (MicroRNA)IBA 06/2023 - 01/2014
8	Biomarkers (Surrogate Marker)IBA 11/2023 - 04/2015
8	Deubiquitinating EnzymesIBA 11/2022 - 06/2014
7	Celecoxib (Celebrex)FDA Link 12/2023 - 01/2018
6	CytokinesIBA 04/2024 - 02/2011
6	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 10/2016
5	Thioacetamide (Thioacetamid)IBA 12/2023 - 07/2020
5	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 12/2023 - 03/2014
5	SeleniumIBA 10/2023 - 05/2021
5	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2022 - 09/2008
5	B7-H1 AntigenIBA 01/2022 - 01/2017
5	CaspasesIBA 01/2018 - 01/2014
4	RNA (Ribonucleic Acid)IBA 04/2024 - 01/2023
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2023 - 03/2015
4	Protein Kinases (Protein Kinase)IBA 07/2023 - 01/2019
4	Phosphotransferases (Kinase)IBA 07/2023 - 11/2016
4	Small Interfering RNA (siRNA)IBA 03/2023 - 01/2017
4	Capecitabine (Xeloda)FDA Link 01/2023 - 01/2022
4	Imatinib Mesylate (Gleevec)FDA Link 01/2017 - 01/2014
3	Messenger RNA (mRNA)IBA 04/2024 - 01/2021
3	Dextran SulfateIBA 04/2024 - 01/2021
3	16S Ribosomal RNAIBA 04/2024 - 01/2021
3	Paclitaxel (Taxol)FDA LinkGeneric 03/2024 - 04/2007
3	AcidsIBA 02/2024 - 11/2020
3	glycyrolIBA 02/2024 - 01/2019
3	Butyrates (Butyrate)IBA 10/2023 - 02/2020
3	Circular RNAIBA 06/2023 - 01/2023
3	UbiquitinIBA 01/2023 - 06/2014
3	methylselenic acidIBA 01/2023 - 06/2021
3	PlatinumIBA 01/2023 - 09/2016
3	Gemcitabine FDA Link 01/2023 - 10/2016
3	Antineoplastic Agents (Antineoplastics)IBA 10/2022 - 02/2017
3	FullerenesIBA 10/2022 - 06/2020
3	AntioxidantsIBA 12/2021 - 06/2020
3	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2021 - 01/2016
3	BilirubinIBA 01/2021 - 01/2017
3	GoldIBA 01/2018 - 07/2014
3	Peptide Hydrolases (Proteases)FDA Link 01/2018 - 06/2014
3	Proteasome InhibitorsIBA 01/2018 - 01/2014
3	Auranofin (Ridaura)FDA Link 01/2016 - 07/2014
3	gambogic acidIBA 04/2015 - 01/2013
3	Bortezomib (Velcade)FDA Link 07/2014 - 01/2013
2	LipidsIBA 04/2024 - 09/2021
2	Volatile Fatty AcidsIBA 04/2024 - 10/2023
2	6-methyladenineIBA 03/2024 - 11/2023

Therapy/Procedure

58	Radiotherapy 11/2023 - 08/2002
35	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 08/2022 - 03/2004
30	Drug Therapy (Chemotherapy) 01/2023 - 07/2003
28	Therapeutics 03/2024 - 01/2014
28	Chemoradiotherapy 02/2024 - 10/2003
9	Induction Chemotherapy 02/2024 - 05/2016
7	Aftercare (After-Treatment) 01/2021 - 08/2002
6	Immunotherapy 04/2024 - 01/2020
5	Neoadjuvant Therapy 01/2019 - 11/2015
5	Re-Irradiation 06/2017 - 10/2012
4	Adjuvant Chemotherapy 10/2022 - 01/2011
3	Fecal Microbiota Transplantation 04/2024 - 01/2021
3	Intraperitoneal Injections 12/2023 - 01/2017
3	Salvage Therapy 01/2018 - 02/2016